Supriya Lifescience Limited (NSE:SUPRIYA)
India
· Delayed Price · Currency is INR 788.00
+56.20 (7.68%)
Apr 2, 2025, 3:29 PM IST
Supriya Lifescience Market Cap
Supriya Lifescience has a market cap or net worth of 58.90 billion as of April 2, 2025. Its market cap has increased by 116.38% in one year.
Market Cap
58.90B
Enterprise Value
58.11B
Revenue
6.71B
Ranking
n/a
PE Ratio
33.78
Stock Price
788.00
Market Cap Chart
Since December 28, 2021, Supriya Lifescience's market cap has increased from 31.46B to 58.90B, an increase of 87.23%. That is a compound annual growth rate of 21.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 58.90B | -1.08% |
| Dec 31, 2024 | 59.54B | 135.04% |
| Dec 29, 2023 | 25.33B | 33.91% |
| Dec 30, 2022 | 18.92B | -51.41% |
| Dec 31, 2021 | 38.93B | 23.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,074.91B |
| Divi's Laboratories | 1,473.27B |
| Cipla | 1,166.40B |
| Mankind Pharma | 1,014.16B |
| Apollo Hospitals Enterprise | 953.62B |
| Zydus Lifesciences | 882.97B |
| Aurobindo Pharma | 658.72B |
| Alkem Laboratories | 578.16B |